Skip to main content

Home/ Healthcare 2.0/ Dermatophytic Onychomycosis Market: Opportunities and Investment by Winning Companies
shawnandrew

Dermatophytic Onychomycosis Market: Opportunities and Investment by Winning Companies - 1 views

Onychomycosis healthcare drugs Medical

started by shawnandrew on 18 Feb 19
  • shawnandrew
     
    Onychomycosis is a fungal infection of the fingernails or toenails, wherein the bed of the nail and the plate under the surface of the nail are affected.The global dermatophytic onychomycosis market is driven by rise in prevalence of dermatophytic onychomycosis, increase in geriatric population prone to diabetes, sedentary lifestyle, surge in number of R&D activities, and high demand for aesthetic appearing nails.
    The key players operating in this market include Valeant Pharmaceuticals International Inc., Novartis AG, Pfizer Inc., Johnson & Johnson

    Get sample copy of this report @ https://www.alliedmarketresearch.com/request-toc-and-sample/4396?utm_source=PC_Diigo

To Top

Start a New Topic » « Back to the Healthcare 2.0 group